Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study

BACKGROUND: To monitor long-term outcomes of ocrelizumab treatment. OBJECTIVE: To evaluate safety and treatment outcomes of ocrelizumab in a community-based multiple sclerosis (MS) population. METHODS: Adult patients with MS prescribed ocrelizumab were eligible. Chart reviews were conducted at the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Smoot, Kyle, Chen, Chiayi, Stuchiner, Tamela, Lucas, Lindsay, Grote, Lois, Cohan, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264886/
https://www.ncbi.nlm.nih.gov/pubmed/34308352
http://dx.doi.org/10.1136/bmjno-2020-000108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264886/
https://www.ncbi.nlm.nih.gov/pubmed/34308352
http://dx.doi.org/10.1136/bmjno-2020-000108

Ejemplares similares